Matt Moulding's online retailer The Hut Group and its subsequent flotation have both proven a resounding success.
The Sunday Times's Emma Dunkley told readers to 'sell' shares of International Personal Finance, citing the still substantial uncertainty in its operating environment and the need to refinance a €397m (£367m) bond by next April.
The Sunday Times's Jill Treanor thinks shares of B&M are worth holding onto despite their v-shaped recovery from the worst of the Covid-19 pandemic.
The Brexit negotiations will be over in days unless the EU realises Britain is serious about no-deal, government sources have warned. The eighth round of talks with Brussels begin on Tuesday, with progress crucial if the two sides are to finally reach an agreement. It comes as the Telegraph reported on Saturday that the EU’s chief negotiator Michel Barnier is to be sidelined in a bid to break the deadlock. But as the deadline on the discussions fast approaches, No 10 insiders say there will be no deal unless the bloc shows “more realism” on the “scale of the change that results from our departure”.
The Mail on Sunday's Midas column labelled shares of Airtel a "bargain", pointing to the fast growth in its sales, promising outlook and generous dividend payouts to back up its case.
The Mail on Sunday's Midas column told readers to 'buy' shares in Canadian copper miner Taseko in anticipation of further top-line growth, not least as its Florence mine in the US comes onstream.
The Mail on Sunday's Midas column told readers to 'buy' shares of Byotrol given the quality of the hand sanitiser maker's products and the large and growing market opportunity both amid and after the Covid-19 pandemic.
The Sunday Times's Emma Dunkley sounded a positive note on shares of Experian but nevertheless labelled the stock a 'hold' due to its valuation and the risks of a second wave of Covid-19.
Despite the sag in Durex in sales during the first half at Reckitt Benckiser's, the Mail on Sunday's Rosie Murray-West told readers to 'hold' onto the shares.
The Sunday Times's Peter Evans told readers to 'buy' shares of Whitbread as the hotel and restaurant operator prepares to reopen its establishments, but conceded that a second lockdown would be "disastrous".
The Mail on Sunday's Midas column touted the long-term potential for Gresham House, the green investor, including for its dividend payout.
The Sunday Times's Sabah Meddings told readers of her 'Inside the City' column to 'buy' shares of PureTech, citing the the drug maker's ingenious 'portfolio' approach and ample pipeline of treatments in various phases of development.
The novel coronavirus pandemic is forcing whole industries to adapt, not least healthcare and the NHS.
The Sunday Times's Sam Chambers thinks readers should 'sell' shares of Hammerson.
The Mail on Sunday's Midas column recommends that investors stick with Ideagen, pointing to software developer's big base of recurring revenues and brisk uptake of its products in the wake of the Covid-19 pandemic.
Shares of Homeserve should "continue to do well", the Mail on Sunday's Midas column said, pointing to the company's growth outlook, plans for international expansion and - above all - the drive of its founder and chief executive as the main reasons behind its confidence in the outfit.
The Sunday Times's Sabah Meddings told readers to 'buy' shares of Hikma Pharmaceuticals, touting it as a potential beneficiary of the White House's 'America First' strategy to promote US manufacturing.
The difficult outlook in almost every sense has experts believing that conditions are set fair for the price of gold, which bodes well for gold miners as well as for those working for them, such as Capital Drilling, said the Mail on Sunday's Midas column.
The Mail on Sunday's Midas column recommended readers 'buy' shares of Braemar Shipping pointing out a raft of reasons why it believed the shipping broker was deeply oversold.
Hold onto shares of Begbies Traynor, the Mail on Sunday's Midas column said, predicting that the stock would continue to rise.
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news articles and we may not share the views of the author. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.